SCOTTSDALE, Ariz., Oct. 17, 2024 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation's largest providers of outpatient mental health care, will issue its third quarter 2024 earnings release before the market opens on Thursday, November 7, 2024. LifeStance will host a live earnings conference call to discuss third quarter results on November 7, 2024, at 8:30 a.m. Eastern Time. To participate in the call, please dial 1-800-715-9871, domestically, or 1-646-307-1963, internationa ...

Election stress is contributing to an increase in anxiety and strained relationships, reinforcing the importance of accessible mental healthcare SCOTTSDALE, Ariz., Oct. 8, 2024 /PRNewswire/ -- A LifeStance Health survey released today reveals how widespread election-related anxiety is impacting Americans' mental health, straining their personal relationships and prompting many to limit social media exposure. Nearly four out of five (79%) respondents said the upcoming U.S. presidential election has caused th ...

TORONTO, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. ("Lifeist" or the "Company") (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: LFSWF), a health-tech company that leverages advancements in science and technology to support human wellness in innovative ways, is pleased to report that, further to its news release dated June 25, 2024, it has completed the sale today of the shares (the "Closing") of CannMart Inc. ("CannMart"), a B2B wholesale distribution business facilitating recreational cannabis sales ...

LifeStance Health Group (LFST) closed the last trading session at $6.26, gaining 11.6% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $7.93 indicates a 26.7% upside potential. The mean estimate comprises seven short-term price targets with a standard deviation of $1.43. While the lowest estimate of $6 indicates a 4.2% decline from the current price level, the most optimistic analy ...

TORONTO, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. (TSXV: LFST) (FRANKFURT: M5B0) (OTCMKTS: LFSWF) My Fellow Shareholders, Further to my previous letter of August 15, 2024, we wish to remind you of the reasoning behind the strategic decision to divest Lifeist of CannMart Inc. ("CannMart") via a sale to Simply Solventless Concentrates Ltd. ("SSC") per our press release of June 25, 2024, and why shareholders should vote in favor of the transaction at the Annual and Special Meeting on September 5 ...

公司合作相关 - Lifeist旗下美国生物科学子公司Mikra已聘请impact.com部署其合作管理平台[1] - impact.com副总裁表示期待支持Mikra的合作战略以推动业务增长[2] - Mikra首席执行官称选择impact.com是因其工具符合公司目标能推动销售和客户获取[3] - Mikra致力于在合作和联盟营销领域大力拓展销售工作[4] 行业相关 - 2022年全球合作与联盟营销价值204亿美元预计2031年达398亿美元[3] 公司业务相关 - Mikra致力于推动生物科学发展通过保护细胞健康增加活力年限[5] - Lifeist致力于将有科学依据的天然产品推向市场[5] - impact.com是全球领先合作管理平台支持超4000个品牌的225000个合作关系[6] 公司概况相关 - Lifeist利用科技构建变革人类健康的公司旗下有Mikra和CannMart等业务单元[7] - 可通过相关链接获取Lifeist及其业务信息[8]

文章核心观点 - 公司拥有强大的价值主张,能够持续增长 [4][5] - 美国精神疾病问题严重,为公司提供了广阔的增长空间 [6][7][8][9] - 公司的利润率已经出现转折,未来有望实现双位数利润率 [10][11][12] 公司概况 - 公司是一家提供精神健康服务的医疗服务平台,采用线上线下相结合的模式 [3] - 公司最近公布了2Q24财报,业绩表现良好,收入和利润均超出预期 [3] - 公司持续扩大临床医生规模,同时提升了每位医生的收入水平 [3] - 公司上调了全年收入和利润指引 [3] 公司的价值主张 - 公司的混合模式(线上线下)提高了患者的可及性和便利性 [4] - 线上服务降低了患者的心理障碍,增加了就诊意愿 [4] - 线上服务大幅缩短了患者的等待时间 [4] - 公司的混合模式扩大了地理覆盖范围,提高了医生的利用率 [5] - 公司能够捕捉到之前未被满足的患者需求 [5] 行业现状 - 美国超过五分之一的成年人患有精神疾病 [7] - 约有四分之一的青少年患有严重的精神疾病 [7] - 约有四十分之一的成年人患有严重的精神疾病 [8] - 精神疾病问题严重,如果不加以重视将成为巨大的经济负担 [9] 利润率转折 - 公司利润率在过去几个季度出现了改善 [10][11] - 尽管第三季度利润率有所下降,但这主要是由于季节性因素和前瞻性投资 [12] - 公司有信心在2025财年实现双位数利润率 [12][14] 估值分析 - 基于2025财年的140亿美元EBITDA和21倍的EBITDA估值倍数,公司股价有24%的上涨空间 [13][14] - 与同行相比,公司的盈利能力更强,估值溢价是合理的 [15]

TORONTO, Aug. 21, 2024 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. ("Lifeist" or the "Company") (TSXV: LFST) (FRANKFURT: M5B0) (OTCMKTS: LFSWF), a health-tech company that leverages advancements in science and technology to build breakthrough ventures that transform human wellness, is pleased to announce that its U.S. biosciences subsidiary Mikra Cellular Sciences Inc. ("Mikra") invites customers to sign up for VIP Early Access to the FOCUS Pre-Sale at https://wearemikra.com/pages/focus-signup-page. Mikra's n ...

TORONTO, Aug. 16, 2024 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. ("Lifeist" or the "Company") (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: LFSWF), a health-tech company that leverages advancements in science and technology to build breakthrough ventures that transform human wellness, is pleased to report that it has completed, pursuant to a share purchase agreement entered into on August 16, 2024 with an arm's length party, the acquisition of the shares of 1000594871 Ontario Corp. ("4871") which holds key intell ...

文章核心观点 - 公司决定出售子公司CannMart是为了确保Lifeist的短期和长期可行性及成功 [2][3] - 加拿大公众大麻公司面临的监管框架过于昂贵,导致无法实现盈利 [4] - 出售CannMart将为Lifeist带来四大好处:1)直接变现CannMart资产 2)摆脱持续亏损的业务 3)持有Simply Solventless Concentrates Ltd.的股票和期权 4)集中资源发展Mikra Cellular Sciences [5][6][7][8] - 公司相信这次出售是实现股东价值的关键 [9][10] 根据目录分别总结 出售CannMart的原因 - 加拿大公众大麻公司普遍无法实现盈利,行业整体处于长期熊市 [4] - Simply Solventless Concentrates Ltd.是行业内少有的成功案例,公司认为CannMart作为其一部分更有希望成功 [5] 出售CannMart的好处 1. 直接变现CannMart资产,包括现金、贷款、股票等 [5] 2. 摆脱持续亏损的CannMart业务,有利于Lifeist实现正现金流 [6] 3. 持有Simply Solventless Concentrates Ltd.的股票和期权,有望获得资本增值 [7] 4. 集中资源发展Mikra Cellular Sciences,减少其他业务的干扰 [8] 公司对未来的信心 - 公司相信这次出售是实现股东价值的关键,有望在短期和中期内实现现金流正和盈利 [9][10]